Table 1.

Demographics and Characteristics of 17 Depressed Patients With Insomnia

Patient	Age, y	Sex	Doxepin			Antidepressants			Sedatives			Weight, kg
			Dose, mg	Duration, d	Type		Dose, mg	Duration, d	Type	Dose, mg	Duration, d	Baseline	Wk 1	Wk 2	Wk 3
1	44	Female	4	4	Citalopram		20	33	None			61	NA	NA	NA
					Trimipramine		100	15
					Trazodone		75	9
2	43	Female	6	17	Escitalopram		20	17	None			NA	NA	NA	NA
3	47	Female	12	7	Venlafaxine		150	12	None			59	59	NA	NA
4	42	Female	10	10	Citalopram		40	28	None			79	78	NA	NA
5	58	Female	8	27	Tranylcypromine		8	27	None			68	69	69	69
6	56	Female	8	23	Escitalopram		30	23	None			120	120	121	121
7	52	Male	12	22	Bupropion		300	22	None			98	98	100	100
					Mirtazapine		15	7
8	26	Male	20	26	None				Lorazepam	2.5	26	71	70	69	70
9	46	Female	6	24	Citalopram		40	12	None			64	63	NA	NA
					Escitalopram		20	12	None
10	43	Female	8	23	Venlafaxine		225	21	Lorazepam	1.0	21	68	68	68	68
					Bupropion		150	7	None
11	59	Female	6	27	None				None			46	46	46	46
12	79	Female	12	28	Agomelatine		50	28	None			84	84	84	84
13	28	Female	8	14	Citalopram		20	14	None			84	84	84	84
14	64	Female	12	16	Venlafaxine		150	16	None			67	67	68	NA
15	82	Female	6	27	Escitalopram		10	27	None			73	73	73	73
16	27	Female	16	27	Citalopram		40	27	None			NA	NA	NA	NA
17	49	Female	4	8	None				None			NA	NA	NA	NA

Abbreviation: NA = not applicable.